Genitourinary Cancers

David F. McDermott MD and Daniel P. Petrylak MD review data from key genitourinary cancer presentations from the 2015 clinical oncology meeting in Chicago.

Share

Program Content

Activities

  • Lenvatinib ± Everolimus in mRCC
    Improved Survival and Response With Lenvatinib ± Everolimus vs Everolimus Alone in Metastatic RCC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Bristol Myers Squibb

Celgene

Genentech BioOncology

Incyte

Novartis Pharmaceuticals Corporation